DOI QR코드

DOI QR Code

Clinical and Laboratory Features of Pediatric Patients with COVID-19: Systematic Review and Meta-analysis

COVID-19 소아 환자의 임상 양상 및 실험실적 특징: 체계적문헌고찰 및 메타분석

  • Yoon, Ha Young (College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University) ;
  • Cho, Young Ah (College of Pharmacy, Gyeongsang National University) ;
  • Yee, Jeong (College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University) ;
  • Gwak, Hye Sun (College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University) ;
  • Han, Ji Min (College of Pharmacy, Chungbuk National University)
  • 윤하영 (이화여자대학교 약학대학) ;
  • 조영아 (경상대학교 약학대학) ;
  • 이정 (이화여자대학교 약학대학) ;
  • 곽혜선 (이화여자대학교 약학대학) ;
  • 한지민 (충북대학교 약학대학)
  • Received : 2020.10.04
  • Accepted : 2020.12.15
  • Published : 2020.12.31

Abstract

Background: Although the identification of clinical and laboratory features in pediatric COVID-19 patients is essential in establishing an appropriate treatment plan, a systematic review and meta-analysis on the topic has yet to be reported. Methods: We searched MEDLINE, Embase, and Web of Science to access clinical and laboratory characteristics as well as clinical outcomes of children with COVID-19 infection. A meta-analysis using random-effect model was performed to estimate pooled prevalence and 95% confidence intervals. Results: Among the 532 studies initially collected, 12 articles were finally included in the meta-analysis. Among the investigated 320 pediatric patients with COVID-19, fever (48.2%) and cough (39.3%) were the most common symptoms. Almost one third of patients (30.4%) were asymptomatic. In laboratory findings, only 11.4% of pediatric patients experienced lymphocytopenia. Increased inflammatory markers including c-reactive protein (18.6%) and procalcitonin (32.4%) were observed. Only a few patients needed mechanical ventilation and intensive care support, and only one death was reported. Conclusion: Pediatric patients with COVID-19 infection exhibited milder symptoms and more favorable outcomes compared to adults. However, considering the high rate of asymptomatic pediatric patients, close monitoring is required to prevent community infection in asymptomatic conditions and hidden disease progression.

Keywords

References

  1. Kelvin AA, Halperin S. COVID-19 in children: the link in the transmission chain. Lancet Infect Dis 2020;20(6):633-4. https://doi.org/10.1016/s1473-3099(20)30236-x
  2. The World Health Organization. Weekly operational update on COVID-19-7 December 2020. Available from https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---7-december-2020. Accessed December 14, 2020.
  3. Lu X, Zhang L, Du H, et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020;382(17):1663-5. https://doi.org/10.1056/NEJMc2005073
  4. Tregoning JS, Schwarze J. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev 2010;23(1):74-98. https://doi.org/10.1128/CMR.00032-09
  5. Campbell H, Nair H. Child pneumonia at a time of epidemiological transition. Lancet Glob Health 2015;3(2):e65-6. https://doi.org/10.1016/s2214-109x(14)70308-0
  6. The World Health Oraganization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance 2020;21(1):734.
  7. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348(20):1977-85. https://doi.org/10.1056/NEJMoa030666
  8. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13(9):752-61. https://doi.org/10.1016/S1473-3099(13)70204-4
  9. Joanna Briggs Institute. JBI manual for evidence synthesis. Available from https://wiki.jbi.global/display/MANUAL/Appendix+7.3+Critical+appraisal+checklists+for+case+series. Accessed December 14, 2020.
  10. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135. https://doi.org/10.1186/1471-2288-14-135
  11. Su L, Ma X, Yu H, et al. The different clinical characteristics of corona virus disease cases between children and their families in China-the character of children with COVID-19. Emerg Microbes Infect 2020;9(1):707-13. https://doi.org/10.1080/22221751.2020.1744483
  12. Zhou Y, Yang GD, Feng K, et al. Clinical features and chest CT findings of coronavirus disease 2019 in infants and young children. Zhongguo dang dai er ke za zhi 2020;22(3):215-20.
  13. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang ZJ. Novel coronavirus infection in hospitalized infants under 1 year of age in China. JAMA 2020;323(13):1313-1314. https://doi.org/10.1001/jama.2020.2131
  14. Li W, Cui H, Li K, Fang Y, Li S. Chest computed tomography in children with COVID-19 respiratory infection. Pediatr Radiol 2020;50(6):796-9. https://doi.org/10.1007/s00247-020-04656-7
  15. Zheng F, Liao C, Fan QH, et al. Clinical characteristics of children with coronavirus disease 2019 in Hubei, China. Curr Med Sci 2020;40(2):275-80. https://doi.org/10.1007/s11596-020-2172-6
  16. Jiehao C, Jin X, Daojiong L, et al. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features. Clin Infect Dis 2020;71(6):1547-51. https://doi.org/10.1093/cid/ciaa198
  17. Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect 2020;80(5):e7-e13. https://doi.org/10.1016/j.jinf.2020.03.007
  18. Liu W, Zhang Q, Chen J, et al. Detection of Covid-19 in children in early January 2020 in Wuhan, China. N Engl J Med 2020;382(14):1370-1. https://doi.org/10.1056/NEJMc2003717
  19. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 2020;20(6):689-96. https://doi.org/10.1016/s1473-3099(20)30198-5
  20. Wang D, Ju XL, Xie F, et al. Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China. Zhonghua er ke za zhi 2020;58(4):269-74.
  21. Liu M, Song Z, Xiao K. High-resolution computed tomography manifestations of 5 pediatric patients With 2019 novel Coronavirus. J Comput Assist Tomogr 2020;44(3):311-3. https://doi.org/10.1097/RCT.0000000000001023
  22. The World Health Oraganization. Global surveillance for human infection with novel coronavirus (2019-ncov): interim guidance. Available from https://apps.who.int/iris/handle/10665/330857. Accessed December 14, 2020.
  23. The National Health Commision of the People's Republic of China. Protocol on prevention and control of COVID-19 (Edition 6). Available from http://en.nhc.gov.cn/2020-03/29/c_78468.htm. Accessed December 14, 2020.
  24. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395(10223):507-13. https://doi.org/10.1016/s0140-6736(20)30211-7
  25. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutierrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis 2020;34:101623. https://doi.org/10.1016/j.tmaid.2020.101623
  26. Sun P, Qie S, Liu Z, Ren J, Li K, Xi J. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis. J Med Virol 2020;92(6):612-7. https://doi.org/10.1002/jmv.25735
  27. Zhou F, Yu T, DU R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-62. https://doi.org/10.1016/s0140-6736(20)30566-3
  28. Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 Coronavirus disease in China. Pediatrics 2020;58(4):712-3.
  29. Safadi M, Almeida da Silva C. The challenging and unpredictable spectrum of COVID-19 in children and adolescents. Rev Paul Pediatr 2020;39:e2020192. https://doi.org/10.1590/1984-0462/2020/38/2020192
  30. Du W, Yu J, Wang H, et al. Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China. Infection 2020;48(3): 445-52. https://doi.org/10.1007/s15010-020-01427-2
  31. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020;25(10):2000180.
  32. Al-Tawfiq JA. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis 2020;35:101608. https://doi.org/10.1016/j.tmaid.2020.101608
  33. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020;382(10):970-1. https://doi.org/10.1056/NEJMc2001468
  34. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. Lancet 2020;395(10223):514-23. https://doi.org/10.1016/s0140-6736(20)30154-9

Cited by

  1. A Single-Center (Sibiu, Romania), Retrospective Study (March-November 2020) of COVID-19 Clinical and Epidemiological Features in Children vol.10, pp.16, 2020, https://doi.org/10.3390/jcm10163517